Survey Reveals that Study Start-Up is the Latest Target in the March to Virtual Clinical Trials
As clinical trials ground to a halt in Q1 of this year, no one knew how our industry would eventually move forward. Now, 6 months…
Molly Bryant
Are You About to Launch a Clinical Trial? Pump Your Brakes.
As the coronavirus continues to spread and dominate the media, we are inundated with advice…
Kelly Ritch
One Key Approach to Reducing Risk in Clinical Operations
There are many ways a clinical trial can go wrong: There might be delays in site identification, initiation, or…
Kelly Ritch
Pandemics Like Coronavirus Could Provide A Watershed Moment for Clinical Research
Above image: countries with confirmed COVID-19 cases as of March 10th. Credit: CDC.gov Below image:…
Joel Selzer
Interview: Managing Studies In A Rapidly Changing Treatment Environment
We recently spoke with Joann Peters, Vice President Clinical Operations at Geneos Therapeutics, a biotech…
Kelly Ritch
Recapping the Conversations at SCOPE 2020
After record attendance and a high energy atmosphere at SCOPE 2020 in Orlando last week,…
Joel Selzer
[Interview] Increasing Study Confidence In the Eyes of a CRO Executive
We recently talked with Mike Keens, Chief Operating Officer at Firma Clinical Research, a clinical…
Kelly Ritch
Join the Conversation at SCOPE with ArcheMedX
SCOPE 2020 is almost upon us! This year, ArcheMedX is helping to shape the conversation…
Joel Selzer
[Interview] Keeping It Personal: CRO Executive Uncovers the Value of Analytics in the Management of Clinical Trials
Wecome to another issue of our interview series Conversations in Clinical Trial Readiness, by ArcheMedX.…
Kelly Ritch
Evaluating Risk: Is Your Staff Clinical Trial Ready?
Does this scenario ring a bell? Your trial is about to go live - and…
Kelly Ritch
Updated: How Clinical Operations Teams Can Improve Trial Readiness Through Training in 2020
When I first wrote this blog, I anticipated that 2020 would be a year that…
Kelly Ritch
Industry insights you won’t delete. Delivered to your inbox monthly.
[Interview] New Directions in Clinical Trial Preparation and Preparedness
We recently talked with Atlantic Research Group (ARG) executives Shay Brill, VP at ARG, and Erin Farris, Senior Director Project Management, about clinical trial operations, how they…
Kelly Ritch
[Interview] Moving the Chess Pieces: A Merck Exec’s Take on the Art of Staffing Clinical Trial Projects
We recently talked with Adam Kinsey, Executive Director, Clinical Sciences and Study Management—Oncology at Merck,…
Kelly Ritch
Meet ArcheMedX During the 38th Annual JP Morgan Healthcare Conference
ArcheMedX is heading west January 12th-15th for the 38th Annual JP Morgan Healthcare Conference. Let's…
Joel Selzer
We Need Less Guessing In Our Clinical Trial Site Selection Process
When sponsors and contract research organizations (CROs) make decisions about which sites to include in…
Kelly Ritch
How Might We Improve the Value of the Principal Investigator Meeting?
The principal investigator (PI) meeting is a well-established (and expensive) tradition in the pharmaceutical industry.…
Kelly Ritch
The Final Frontier of Learning: A Walk Through Space (and Time)
One of the best analogies on learning that I ever learned came in a rather…
Brian S McGowan, PhD
Experience ArcheMedX For Yourself
See how the ArcheMedX Platform can transform your organization’s learning and insights